Cube Labs S.P.A. (IT:CUBE) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cube Labs, an Italian venture builder in the healthcare technology sector, has secured significant funding for its startups Adamas Biotech and DTech. Adamas Biotech received €425,700 to develop a nutraceutical for intestinal health, while DTech obtained €393,700 for a protective biospray and digital platform. These contributions, backed by the National Biodiversity Future Center, will advance Cube Labs’ innovative healthcare projects.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.